WEREWOLF THERAPEUTICS, INC. (HOWL) Free cash flow 2020–2025
WEREWOLF THERAPEUTICS, INC. (HOWL) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$60.3MFY2025 · since FY2020: -$19.2M → -$60.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$60.3M | -6.8% |
| FY2024 | -$56.4M | -69.1% |
| FY2023 | -$33.4M | +24.5% |
| FY2022 | -$44.2M | -1.9% |
| FY2021 | -$43.4M | -126.1% |
| FY2020 | -$19.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More HOWL financial trends
HOWL RevenueHOWL Net incomeHOWL Net marginHOWL Gross profitHOWL Gross marginHOWL Operating incomeHOWL Operating marginHOWL Operating cash flowHOWL Capital expendituresHOWL Return on equityHOWL Stock buybacksHOWL Dividends paidHOWL Total assetsHOWL Total liabilitiesHOWL Shareholders’ equityHOWL overview →